MINNEAPOLIS & MELBOURNE, Australia--(BUSINESS WIRE)--Osprey Medical Inc. (ASX: OSP) today announced that Dr. Roxana Mehran will be the Principal Investigator (PI) of the AVERT Trial. This trial will evaluate the Company’s AVERT™ System for a marketing claim expansion to include “reduction of Contrast Induced Nephropathy (CIN)” for patients undergoing angiogram or stenting procedures.
Help employers find you! Check out all the jobs and post your resume.
